Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/31/2025

Hepatitis Laboratory Workup for Elevated Liver Enzymes

Core Viral Hepatitis Panel

  • The American Gastroenterological Association recommends ordering hepatitis B surface antigen (HBsAg) and hepatitis C antibody (with reflex PCR if positive) as part of the core viral hepatitis screen for all patients with elevated liver enzymes 1, 2
  • Hepatitis B surface antigen (HBsAg) identifies active hepatitis B infection, and hepatitis C antibody with automatic follow-on PCR testing if antibody is positive confirms active infection 1, 2

Extended Viral Hepatitis Testing Based on Clinical Context

  • For marked transaminase elevations (ALT >1000 U/L), consider additional acute viral hepatitis serologies, including hepatitis A IgM, hepatitis E IgM, and cytomegalovirus (CMV) serology, especially in immunocompromised patients 3, 5
  • For patients with HIV or high-risk populations, anti-hepatitis D (HDV) antibody, HBV DNA quantification, and anti-HBc (hepatitis B core antibody) are indicated 5, 6

Complete Initial Laboratory Panel

  • A comprehensive workup should include complete blood count with differential, complete metabolic panel, prothrombin time/INR, autoimmune markers, iron studies, and abdominal ultrasound 1, 2, 4, 7

Critical Pitfalls to Avoid

  • The American Association for the Study of Liver Diseases advises against simply repeating the same abnormal liver tests without pursuing the underlying etiology, as 75% of abnormal liver enzymes remain abnormal at 2 years 1
  • In HIV-positive patients, always test both HBsAg and anti-HBc, as occult HBV infection can occur with high HBV DNA levels despite negative HBsAg 5, 6

Timing and Follow-Up

  • For patients with positive viral hepatitis markers, immediate referral to hepatology is indicated for treatment consideration, as these represent immediately treatable causes of liver disease 1, 2
  • Monitor ALT every 3-6 months for chronic hepatitis B patients not meeting treatment criteria, with more frequent monitoring if ALT becomes elevated 6